-
-
-
-
-
-
Virus Hours post-infection Virus strain Cell Accession number DENV-2 72 TSV01 A549 PRJNA552644 Flu-A – PR8 A549 PRJNA495858 Flu-B – B/Yamagata A549 PRJNA605905 ZIKV 48 FSS13025 hiNPCs PRJNA551246 48 PE243V hiNPCs HCV 12 – Huh7 PRJNA559203 36 – Huh7 60 – Huh7 WNV – – A549 PRJNA577579 CCHFV 24 – Huh7 PRJNA549926 72 – Huh7 24 – HepG2 72 – HepG2 EBV – Akata differentiated NOKs PRJNA555053 – Akata undifferentiated NOKs MV – – MSC (5H) PRJNA545099 – – MSC (hTERT) RSV 24 A2 A549 PRJNA615032 SARS-CoV-2 24 USA-WA1/2020 A549 PRJNA615032 24 USA-WA1/2020 NHBE RHV 6 – Calu3 PRJNA609228 24 – Calu3 Table 1. Summary of samples used in this study.
-
Dataset Number of DEGa Number of DEHERVb Up-regulated Down-regulated Total Up-regulated Down-regulated Total DENV-2 2942 1759 4701 2352 681 3033 Flu-A 5341 3789 9130 4810 1989 6799 Flu-B 3667 1877 5544 1408 1078 2486 ZIKV_F 1072 274 1346 536 68 604 ZIKV_P 408 49 457 270 12 282 HCV_12h 4 4 8 0 0 0 HCV_36h 354 49 403 152 2 154 HCV_60h 1118 345 1463 208 33 241 WNV 825 52 877 349 6 355 CCHFV_Huh7_24h 12 0 12 6 0 6 CCHFV_Huh7_72h 559 348 907 147 61 208 CCHFV_HepG2_24h 44 1 45 20 0 20 CCHFV_HepG2_72h 121 77 198 45 8 53 EBV_differented-NOKs 237 772 1009 245 146 391 EBV_undifferented-NOKs 90 173 263 70 36 106 MV_MSC(5H) 1383 115 1498 1128 85 1213 MV_MSC(hTERT) 733 191 924 319 64 383 RSV 430 229 659 69 6 75 SARS-CoV-2_A549 32 1 33 6 0 6 SARS-CoV-2_NHBE 104 23 127 14 3 17 RHV_6h 1 0 1 2 1 3 aDifferentially expressed human gene; bdifferentially expressed HERV. Table 2. Summary of differentially expressed human genes and HERVs in each dataset.
Figure 5 个
Table 2 个
